ArticleESMO open2020

Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer.

Morena Fasano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.